Trade Gilead GILD

Sell
 Buy

Gilead live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

Gilead News

Emma Rose 2025 Nov 15, 00:00

US Stock Market Outlook: Jitters and Potential Catalysts

Ava Grace 2025 Nov 15, 00:00

Fiscal Firefighting: US & Japan's Unorthodox Inflation Strategy

Sophia Claire 2025 Nov 15, 00:00

Guggenheim Partners Sees Fed Rate Cut in December Amid Economic Slowdown Concerns

Ava Grace 2025 Nov 15, 00:00

US Government Shutdown Aftermath: Rate Cut Concerns and Market Uncertainty

Frances Wang 2025 Nov 13, 16:00

Commodity market today: Gold prices are rising, what is XAU/USD prediction?

Frances Wang 2025 Nov 13, 16:00

AI stocks are trending: Qualcomm stock, Nvidia (NVDA), AMD stock

Ghko B 2025 Nov 12, 16:00

VOO performance analysis: What is the VOO ETF performance prediction?

Ghko B 2025 Nov 12, 16:00

Easy stocks for beginners: MSFT stock, AAPL stock, NVIDIA (NASDAQ: NVDA)

Frances Wang 2025 Nov 12, 16:00

Stellar climbs 4% today: Stellar (XLM) Price Prediction for 2025, 2026, 2030

Noah Lee 2025 Nov 10, 09:10

x402 Ecosystem Competition Analysis: Launchpads, Facilitators, and Providers

Latest news

Show more
Emma Rose 2025 Nov 15, 02:40

Bitcoin & Ethereum Plunge: US Market Pressures Unveiling Underlying Causes

Sophia Claire 2025 Nov 15, 02:30

Crypto Market Bottoms: Contrarian Indicators and Sentiment Analysis

Ava Grace 2025 Nov 15, 01:40

Crypto Weekly Recap: Market Trends and Regulatory Updates

Liam James 2025 Nov 15, 00:40

CFTC Likely to Dominate Crypto Oversight, Says ProCap BTC CIO

Liam James 2025 Nov 15, 00:00

Russian Oil Exports Disrupted at Novorossiysk Port: Drone Attack Fuels Price Surge

Emma Rose 2025 Nov 15, 00:00

Economists Fear Data 'Black Hole' in Wake of US Government Shutdown

Ava Grace 2025 Nov 15, 00:00

US Government Reopens, Deep Divisions Remain After Shutdown

Ava Grace 2025 Nov 15, 00:00

Gold Price Volatility Persists Amid Fed Rate Hike Uncertainty

Info

Spread

0.81

Spread (%)

0.6506 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

14:31 - 20:59

Tuesday

14:31-20:59

Wednesday

14:31-20:59

Thursday

14:31-20:59

Friday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

155333099520

Shares Outstanding

1240679623

Earnings Date (Next)

2013-01-28

Div Yield

2025-12-30

Ex-Dividend Date

2025-12-15

Forward annual dividend rate

3.16

Forward annual dividend yield

0.0252

EPS

6.46

Learn more about this instrument

Gilead Gilead Sciences Inc
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; Marengo Therapeutics; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Ghko B 2025 Nov 13, 16:00

Which broker is best for bitcoin trading: Cheapest Ways to Buy Bitcoin In 2026

Ghko B 2025 Nov 13, 16:00

Crypto day trading strategy: How to day trade crypto as a beginner?

Ghko B 2025 Nov 13, 16:00

Commodity trading strategy: WTI Oil faces potential decline, what’s next?

Trustpilot